// App-Quantinova.ai

: Associations Between Mean Apparent Propagator MRI and Cerebrospinal Fluid Markers of AD Pathology, Neurodegeneration, and Glial Activation, in Cognitively Unimpaired Adults

Researchers

Presenter

  • Jason F Moody

Principal Investigators

  • Douglas C Dean

  • Steven R Kecskemeti

  • Kaj Blennow

  • Henrik Zetterberg

  • Cynthia M Carlsson

  • Sterling C. Johnson

  • Andrew L Alexander

  • Barbara B. Bendlin

Medical Centers

  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison

  • Department of Medical Physics, University of Wisconsin, Madison, WI

  • Department of Statistics, University of Wisconsin-Madison

  • Geriatric Research, Education and Clinical Center, Madison VA Hospital

  • Waisman Center, University of Wisconsin, Madison

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin- Madison School of Medicine and Public Health

  • Department of Medical Physics, University of Wisconsin, Madison, WI

  • Waisman Center, University of Wisconsin, Madison

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • Geriatric Research Education and Clinical Center, William S. Middleton Veterans Hospital

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • UK Dementia Research Institute

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Department of Statistics, University of Wisconsin-Madison

  • Waisman Lab of Brain Imaging & Behavior, University of Wisconsin Madison, Madison, WI

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Amyloid beta 42

  • Chitinase 3 Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A